ENTA · Enanta Pharmaceuticals Inc

$12.57 -0.04 (-0.32%)

Market Cap

$366.68M

29.08M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-07-02	—
8-K	2026-06-23	—
8-K	2026-06-18	—
10-Q	2026-05-13	2026-03-31
8-K	2026-05-11	—
Investor Event Transcript	2026-03-31	—
8-K	2026-03-26	2026-03-20
8-K	2026-03-12	2026-03-11
10-Q	2026-02-11	2025-12-31
8-K	2026-02-09	—
DEF 14A	2026-01-26	2026-03-11
10-K	2025-11-19	2025-09-30
8-K	2025-11-17	—
8-K	2025-10-01	2025-09-30
8-K	2025-09-29	—
8-K	2025-09-29	—
8-K	2025-08-27	2025-08-26
8-K	2025-08-20	—
10-Q	2025-08-13	2025-06-30
8-K	2025-08-11	—
10-Q	2025-05-14	2025-03-31
8-K	2025-05-12	—
8-K	2025-03-17	2025-03-13
10-Q	2025-02-12	2024-12-31
8-K	2025-02-10	—
DEF 14A	2025-01-27	2025-03-13
8-K	2024-12-09	—
10-K	2024-11-27	2024-09-30
8-K	2024-11-25	—
10-Q	2024-08-07	2024-06-30
8-K	2024-08-05	—
10-Q	2024-05-08	2024-03-31
8-K	2024-05-06	—
8-K	2024-03-12	2024-03-06
10-Q	2024-02-08	2023-12-31
8-K	2024-02-07	—
DEF 14A	2024-01-26	2024-03-06
8-K	2023-12-26	2023-12-19
10-K	2023-11-22	2023-09-30
8-K	2023-11-20	—
10-Q	2023-08-08	2023-06-30
8-K	2023-08-07	—
8-K	2023-06-07	—
10-Q	2023-05-09	2023-03-31
8-K	2023-05-08	—
8-K	2023-04-27	2023-04-25
8-K	2023-03-10	—
8-K	2023-03-07	2023-03-02
10-Q	2023-02-08	2022-12-31
8-K	2023-02-07	—

Showing 1–50 of 90 filings

Key facts CIK 1177648 CUSIP 29251M106 13F (30d) 38 filings 17 filers Visit website Investor relations